News
Market and company headlines
CVS Health (NYSE:CVS) has appointed Jack Hanlon as senior vice president of AI and Analytics for its retail and pharmacy operations. Hanlon previously held senior data and analytics roles at Meta and Reddit, bringing large scale consumer technology experience into CVS Health. The new executive role is focused on applying advanced AI and analytics across CVS pharmacy, front store activity and customer programs. Investors may want to weigh the appointment of Jack Hanlon to lead AI and...

CVS Health’s latest launch of its Health100 AI platform and rapid build out of GLP 1 programs gave investors something very concrete to react to, as the business sharpened its focus on higher margin healthcare services and technology. For CVS Health shareholders, the return from the start of the year was 20.2%, including dividends. If someone had been deciding whether to buy on 1 January 2026, what exactly did they need to believe before any of this news hit the tape? On Simply Wall St, a...
CVS Health is scheduled to post its third-quarter results in November, and analysts project a single-digit earnings rise.

CVS Pharmacy®, the retail division of CVS Health® (NYSE: CVS), today announced an expanded assortment of collectibles, nostalgic favorites, limited-edition products and seasonal finds for fall, introducing new brands, exclusive products and trending products across toys, beauty, snacks and seasonal categories. Rolling out this fall at CVS Pharmacy stores and CVS.com, the assortment is designed to bring an element of discovery to everyday shopping trips.

WOONSOCKET, RI / ACCESS Newswire / October 23, 2026 / Recently, the Grand Opening of Phoenix Residential in Milwaukee marked a milestone for the residents, local leaders, community and development organizations, who helped bring the community to life.Phoenix Residential offers 21 affordable homes for families earning up to 30% and 60% of Area Median Income, with eight units supported by HUD project-based rental assistance.

CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

In the latest trading session, CVS Health (CVS) closed at $93.45, marking a -1.37% move from the previous day.

For questions about this article or underlying research, email help@trefis.com.

CVS Health (NYSE:CVS) has introduced new pharmacy-focused store formats aimed at expanding local access to pharmacy care in select communities. The business is working with The Midlife Collective on a research study examining women's midlife health experiences, paired with a future documentary. The collaboration is expected to explore cultural narratives around midlife health for women and how support systems respond to their needs. Both the new pharmacy-focused locations and the women's...

The national pharmacy retail chain is making a push to win over customers that rivals have abandoned.

As the company's chief information technology officer, Amaresh Siva will lead enterprise tech and AI as the company looks for a return to profitability.

CVS Health's Aetna streamlines prior authorizations, approves more than 95% of eligible requests within 24 hours and expands bundled approvals to speed access to care.

Key TakeawaysBristol Myers Squibb yields 4. 3% and CVS Health yields 3.

On August 5, 2026, CVS Health (CVS) management raised its fiscal 2026 revenue forecast to at least $414 billion, up from $405 billion in May. Yet the stock has fallen 11.5% since the close prior to that release, compared with a 1.0% dip for the S&P 500. When a higher financial outlook meets a declining share price, investors should examine the technicals before taking the new numbers at face value. So does the CVS Health chart agree with the raise.

WOONSOCKET, RI / ACCESS Newswire / October 16, 2026 / Originally published on Company NewsroomHealth care consumers increasingly expect the same convenience and connectivity they experience in other aspects of their daily lives. As digital experiences become more personalized and intuitive, is working to make care easier to access, navigate and understand.

CVS customers: You may be eligible for money from a class-action lawsuit settlement. Here's how to file a claim before the deadline.

The latest trading day saw CVS Health (CVS) settling at $92.17, representing a +1.97% change from its previous close.

CVS Health®(NYSE: CVS) today announced a new collaboration with The Midlife Collective, a media company and community platform dedicated to changing the cultural conversation around women and aging. As part of the collaboration, the two organizations will conduct a research study designed to better understand the physical, emotional, social and life experiences of women in midlife. Findings from the study will help inform The Midlife Collective's upcoming documentary, Her Second Act, which will

CVS Health (NYSE:CVS) agreed to a US$315 million settlement resolving allegations of improper opioid prescription dispensing. The accord concludes federal claims that CVS pharmacies filled opioid prescriptions that allegedly violated US controlled substances law. CVS Health committed to new controlled substance oversight measures as part of the settlement, including tighter monitoring of opioid dispensing. This opioid settlement and the fresh compliance obligations only capture one piece of...

Prosecutors say the company filled unnecessary prescriptions that fueled the opioid epidemic. A spokesperson for CVS said the company admitted to no wrongdoing and “strongly disagreed” with the case’s claims.

CVS Health (CVS:NYSE) agreed on Tuesday, October 13, to pay $315 million to settle a Justice Department lawsuit over opioid prescriptions, Reuters reported. The government alleged that CVS pharmacies filled invalid prescriptions for opioids and other controlled substances from October 2013 through December 2025, then billed Medicare and other federal programs for many of them.

Pharmacy-focused sites are opening in select communities to help increase access to pharmacy careOriginally published on Company NewsroomWOONSOCKET, RI / ACCESS Newswire / October 14, 2026 / ® (NYSE:CVS) today unveiled its first pharmacy-focused CVS Pharmacy® in the Boston area. The new pharmacy, located at 32 Warren Street in Roxbury, will help bridge gaps in pharmacy care, and make it easier for community members to access medications, immunizations and other health care services provided by p

If you own CVS Health (CVS), the primary focus shifts from 2026 execution toward potential headwind variables heading into 2027. Management raised its 2026 earnings outlook on its fiscal Q2 2026 call in August. It also gave an early read on 2027, a quarter sooner than usual. One warning in that read came with no number. Over the past three months, the shares lost 15.2%, while the S&P 500 gained 5.0%. What is the 2027 problem CVS would not put a number on.

CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

The company also announced its first acquisition in the UK days after the conclusion of the Competition and Markets Authority probe.

CVS Group (LON:CVSG) reported higher revenue, adjusted EBITDA and adjusted earnings per share for the year ended June 30, 2026, while highlighting softer U.K. companion-animal demand late in the year and continued expansion in Australia. Revenue rose 5.9% to £712.8 million, supported by acquisition

Following the Tennessee Department of Health's recent confirmation of nine measles cases in the state, CVS Health® (NYSE:CVS) is reminding Tennesseans that the measles-mumps-rubella (MMR) vaccine is available at CVS Pharmacy® and MinuteClinic® locations statewide for eligible patients.

Four winning designs will be featured on limited-edition CVS brand bandages for sale in 2027Originally published on Company NewsroomWOONSOCKET, RI / ACCESS Newswire / September 23, 2026 / ® (NYSE:CVS) recently announced the launch of its nationwide "Wear Your HeART" Bandage Art Contest, inviting people across the United States to submit original artwork inspired by the importance of protecting personal, family and community health.The contest offers artists, students, families and community grou

Polaris Capital Management, an investment management company, released its second-quarter 2026 investor letter for “Global Equity Strategy”. The letter can be downloaded here. Global markets delivered strong gains during the quarter, supported by an AI-driven earnings rally despite elevated interest rates, inflation concerns, and geopolitical uncertainty. Polaris Global Equity Composite (net of fees) returned 13.26% […]

CVS Health has delivered a 36.9% share price gain over the past three years, even after a recent pullback. This puts fresh focus on whether that climb still lines up with what the business earns. With earnings in the spotlight and the stock giving back some ground in recent weeks, the key issue for you is whether today's valuation is properly grounded in its profit power. The 36.9% return over three years raises the question of how much of that move reflects lasting earnings strength versus...
Key Stats for Eli Lilly StockPrice change for Eli Lilly stock in last 6 months: 27%$LLY Stock Price as of Sep. 21: $1,16552-Week High: $1,292$LLY Stock Price Target: $1,325What Happened?Eli Lilly (LLY) stock is drawing fresh attention today after Guggenheim raised its price target to $1,284 from $1,273 and maintained a Buy rating.
Haleon plc (NYSE:HLN) is finding a new growth opportunity in the expanding U.S. population using GLP-1 weight-loss drugs such as Wegovy and Zepbound. According to Reuters, the company has been placing products that can address GLP-1-related side effects in both its normal store locations and dedicated GLP-1 sections at CVS. That strategy has produced an […]
Key Stats for CVS Health StockCurrent Price: $88. 84Target Price (Mid): ~$130Street Target: ~$116Potential Total Return: ~47%Annualized IRR: ~9% / yearWhat Happened?CVS Health (CVS) slid to a $88.

CVS Health (CVS) concluded the recent trading session at $87.6, signifying a -1.4% move from its prior day's close.

CVS raises its 2026 revenue and earnings outlook, but reimbursement pressure, macro headwinds and soft front-store demand could weigh on results.

VIO Med Spa, a nationally recognized, physician-guided medical spa franchise specializing in advanced, non-invasive aesthetic and wellness treatments, has signed a three-unit development agreement to enter South Carolina for the first time, bringing the brand to the greater Charleston area. The first location is expected to open in 2027, with site selection currently underway.
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance providers stocks fared in Q2, starting with CVS Health (NYSE:CVS).

The sale lets Ascension shed insurance risk while Aetna gains a stake in a profitable plan serving high-margin dual-eligible members.
A piece of the company is winding down its operations under CVS Health.

Originally published on Company NewsroomThe new mini-pitch brings safe access to play to Orchards Elementary School in Vancouver, WA, as part of 's multi-year field revitalization commitmentNORTHAMPTON, MA AND WOONSOCKET, RI / ACCESS Newswire / September 18, 2026 / ® (NYSE:CVS) announced it has redeveloped a mini soccer pitch in collaboration with Seattle Reign FC and the club's charitable arm, the RAVE Foundation. The mini-pitch, which is located at Orchards Elementary in Vancouver, WA, is now

Kroger (KR) has cut its 2026 same-store sales outlook and kept its 2026 profit outlook. If you own the stock, the easy comfort is that earnings held. The risk sits inside that comfort. The cost savings holding up profit are the same savings management plans to spend on lower shelf prices, and the stock is down 15% over the past six months.
BTSG faces a $200M 2026 IRA revenue headwind in Home Pharmacy, but efficiency gains and technology are helping protect profitability.
Joanne Armstrong, Chief Medical Officer and Vice President, Women's Health, WOONSOCKET, RI / ACCESS Newswire / September 17, 2026 / Originally published on Company NewsroomDespite affecting millions of women, Polyendocrine Metabolic Ovarian Syndrome, formerly known as Polycystic Ovary Syndrome (PCOS), remains one of the most misunderstood conditions in women's health. PMOS also illustrates a broader challenge: when a condition is defined primarily by its reproductive features, its effects across
Aetna®, a CVS Health® company (NYSE: CVS), is expanding prior authorization bundles across all cancer types for members in eligible1 Medicaid states as of September 1, with plans to expand across all lines of business in 2027. This expansion builds on the success of the initial roll-out, with almost 25% of eligible members receiving a bundled prior authorization, assuring their services have been approved in advance to accelerate their access to care.
When the Federal Reserve lifts rates and signals they may stay elevated for years, the easy-growth playbook breaks. Cash flows today matter more than promises tomorrow, and investors start to care a lot about balance sheet strength, pricing power and dependable dividends. This article walks through three large cap quality defensive stocks that screen well under those rules and explains how the latest Fed move could affect each one. The three stocks below are a sample of what this quality...

Originally published on Company NewsroomKey points * 87% of employers say improving cost transparency is one of the biggest opportunities for PBMs * CVS Caremark offers tools and solutions that provide greater visibility into pharmacy spending and cost driversWOONSOCKET, RI / ACCESS Newswire / October 19, 2026 / Understanding what drives health care costs has become increasingly important across the health care system. Employers, patients, providers and policymakers are looking for clearer insig


This expansion builds on the success of the initial roll-out, with almost 25% of eligible members receiving a bundled prior authorization, assuring their services have been approved in advance to accelerate their access
